Current and Future Applications of Genetic Prostate Cancer Screening In the Urologic Clinic
Identification:
unj_nd14_02
Issue:
November-December 2014
Volume:
Volume 34 Number 6
Credits(Post Test and/or Evaluation Required) Available until 12/31/2016
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure: The author, editor, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.
Urologic Nursing Editorial Board Statements of Disclosure Christine Bradway, PhD, CRNP, FAAN, disclosed that she is a Consultant for Direct Supply, Inc. All other Editorial Board members, as well as the Editor, author, and Education Director, reported no actual or potential conflict of interest in relation to this continuing nursing education article.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Objectives:
Discuss current biomarkers for prostate cancer testing.
Explain the use of genetic testing in prostate cancer screening.
List limitations of genetic testing in prostate cancer screening.